Patients may experience potential side effects after treatment with JUVÉDERM® fillers, which may occur immediately or may be delayed. These can include inflammatory reactions (redness, oedema, erythema, etc), haematomas, induration or nodules, staining or discolouration and/or in thin skin (Tyndall effect) at the injection site, poor or weak filling effect etc.4-12
Adverse events should be reported.
Reporting of Side effects:
UK patients: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can help by reporting side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at ProductSurveillance_EAME@allergan.com. By reporting side effects, you can help provide more information on the safety of this product.
Irish patients: If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via www.hpra.ie.
This is intended for adult (>18yrs) audiences only. You should always consult a healthcare professional to help you decide if JUVÉDERM® is right for you and provide you with a full list of side effects.
Models received a variety of JUVÉDERM® products. Images provided courtesy of Allergan Aesthetics, an AbbVie company. Actual treatment results may vary. Images are for illustrative purposes only.
Jones D, Murphy DK. Dermatol Surg 2013; 39:1602–1612.
Pinsky MA et al. Aesthetic Surg J. 2008;28:17–23.
Callan P et al. Clin Cosmet Investig Dermatol. 2013;6:81–89.
